International Business Machines said Thursday that it had joined forces with Moderna for a case study that evidenced quantum ...

Sales growth driven by continued strong performance from Kisqali (+64% cc), Entresto (+22% cc), Kesimpta (+33% cc), Scemblix (+79% cc), Leqvio (+61% cc) and Pluvicto (+30% cc) Core operating income ...

How Moderna Went From Pandemic Hero to Vaccine Victim The biotech's mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to vaccine rules.

Q2 Holdings, Inc. (NYSE: QTWO), a leading provider of digital transformation solutions for financial services, today announced results for its third q ...

Moderna Inc. (NASDAQ:MRNA) Q2 2024 Earnings Conference Call August 1, 2024 8:00 AM ETCompany ParticipantsStéphane Bancel - Chief Executive OfficerStephen ...

Compared to Q2 2023, we have decreased our operating expenses by more than $600 million in Q2 2024. This reduction highlights our commitment to operational efficiency and financial discipline.

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Moderna Inc. (MRNA) on Thursday reported a loss of $1.28 billion in its second quarter. On a per-share basis, the Cambridge, Massachusetts-based ...

Moderna (MRNA) beats expectations for earnings and sales. Management cuts sales guidance by $0.5-$1.0 billion on concerns about competition for its marketed products and low sales in the EU.

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Moderna Inc. (MRNA) on Thursday reported a loss of $1.28 billion in its second quarter. On a per-share basis, the Cambridge, Massachusetts-based ...

Moderna’s financial results for the second quarter of 2024 reveal a mixed bag of outcomes. The company reported total revenue of $241 million, down from $344 million in the same period last year ...

Moderna Inc’s Stock Price Change Based on Its Q2 Earnings Report The stock market is considered to always be “forward-looking,” which means share prices are established based on the expectations that ...